[1]
TANJUNG, R., WARDATI, Y. and SAPTARINI, N.M. 2021. COST-EFFECTIVENESS ANALYSIS OF PROLANIS OF TYPE 2 DIABETES MELLITUS PATIENTS ON THREE COMMUNITY HEALTH CENTERS IN BANDUNG, INDONESIA. International Journal of Applied Pharmaceutics. 13, 3 (Mar. 2021), 28–31. DOI:https://doi.org/10.22159/ijap.2021.v13s3.05.